Position
Quantbot Technologies LP in Alnylam Pharmaceuticals, Inc.
Back to the book · All holders of ALNY
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$3.01K$397.65 → $330.87
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 350 | $139.2K | — | — | — | 0.0% |
| Q1 2026 | 45 | $14.9K | $330.87 | −$3.01K | −$121.3K | 0.0% |